Cited by 724PI3K/AKT/mTOR signaling in cancerTuberous Sclerosis Complex ResearchMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

A complex interplay between Akt, TSC2 and the two mTOR complexes

Open access

Huang, Jingxiang, Manning, Brendan D.·2009·Biochemical Society Transactions

Open this paper in CoChat — free account

Abstract

Akt/PKB (protein kinase B) both regulates and is regulated by the TSC (tuberous sclerosis complex) 1–TSC2 complex. Downstream of PI3K (phosphoinositide 3-kinase), Akt phosphorylates TSC2 directly on multiple sites. Although the molecular mechanism is not well understood, these phosphorylation events relieve the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1 [mTOR (mammalian target of rapamycin) complex] 1, thereby activating mTORC1 in response to growth factors. Through negative-feedback mechanisms, mTORC1 activity inhibits growth factor stimulation of PI3K. This is particularly evident in cells and tumours lacking the TSC1–TSC2 complex, where Akt signalling is severely attenuated due, at least in part, to constitutive activation of mTORC1. An additional level of complexity in the relationship between Akt and the TSC1–TSC2 complex has recently been uncovered. The growth-factor-stimulated kinase activity of mTORC2 [also known as the mTOR–rictor (rapamycin-insensitive companion of mTOR) complex], which normally enhances Akt signalling by phosphorylating its hydrophobic motif (Ser473), was found to be defective in cells lacking the TSC1–TSC2 complex. This effect on mTORC2 can be separated from the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1. The present review discusses our current understanding of the increasingly complex functional interactions between Akt, the TSC1–TSC2 complex and mTOR, which are fundamentally important players in a large variety of human diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1042/bst0370217

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Self-citation
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365

Flagged first, then by citations

Show all 35 references

1 of the 35 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 723

Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway
Sage, V. L., Cinti, A., Amorim, R., & Mouland, A. J. (2016) · Viruses · doi:10.3390/v8060152 · Cited by 122
The proto-oncogene Pim-1 is a target of miR-33a
Thomas, M., Lange-Grünweller, K., Weirauch, U., Gutsch, D., Aigner, A., Grünweller, A., & Hartmann, R. K. (2012) · Oncogene · doi:10.1038/onc.2011.278 · Cited by 127
GABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene
Fu, C., Cawthon, B., Clinkscales, W. B., Bruce, A., Winzenburger, P. A., & Ess, K. C. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr300 · Cited by 123
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
Torres, A., Torres, K., Pesci, A., Ceccaroni, M., Paszkowski, T., Cassandrini, P. A., Zamboni, G., & Maciejewski, R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-369 · Cited by 124
Inositol Polyphosphate Multikinase Is a Physiologic PI3-Kinase That Activates Akt/PKB
Maag, D., Maxwell, M. J., Hardesty, D. A., Boucher, K. L., Choudhari, N., Hanno, A. G., Ma, J. F., Snowman, A. S., Pietropaoli, J. W., Xu, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017831108 · Cited by 122
Host Metabolism Regulates Intracellular Growth of Trypanosoma cruzi
Caradonna, K. L., Engel, J. C., Jacobi, D., Lee, C., & Burleigh, B. A. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.11.011 · Cited by 121
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120
Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer
Beji, A., Horst, D. A., Engel, J., Kirchner, T., & Ullrich, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1186 · Cited by 120
Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Manzoli, L., & McCubrey, J. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/14728220903136775 · Cited by 123
Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress
Gratia, S., Kay, L., Potenza, L., Seffouh, A., Novel-Chaté, V., Schnebelen, C., Sestili, P., Schlattner, U., & Tokarska-Schlattner, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs134 · Cited by 123
mTOR Inhibitors in Advanced Renal Cell Carcinoma
Voss, M. H., Molina, A. M., & Motzer, R. J. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.008 · Cited by 119
The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function
Han, J. M., Patterson, S. J., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00245 · Cited by 120
Autophagy in Human Health and Disease: Novel Therapeutic Opportunities
Giampieri, F., Afrin, S., Forbes-Hernández, T. Y., Gasparrini, M., Cianciosi, D., Reboredo‐Rodríguez, P., Varela‐López, A., Quiles, J. L., & Battino, M. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7234 · Cited by 117
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126
Phosphatidylinositol 3-Kinase: The Oncoprotein
Vogt, P. K., Hart, J. R., Gymnopoulos, M., Jiang, H., Kang, S., Bader, A. G., Zhao, L., & Denley, A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_80 · Cited by 117
A liaison between mTOR signaling, ribosome biogenesis and cancer
Gentilella, A., Kozma, S. C., & Thomas, G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.02.005 · Cited by 120
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway
Nathan, N. R., Keppler‐Noreuil, K. M., Biesecker, L. G., Moss, J., & Darling, T. N. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2016.07.001 · Cited by 115
A Unique Herpesviral Transcriptional Program in KSHV-Infected Lymphatic Endothelial Cells Leads to mTORC1 Activation and Rapamycin Sensitivity
Chang, H. H., & Ganem, D. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.009 · Cited by 113
Global ischemia induces lysosomal-mediated degradation of mTOR and activation of autophagy in hippocampal neurons destined to die
Hwang, J.-Y., Gertner, M. J., Pontarelli, F., Court-Vazquez, B. L., Bennett, M. V. L., Ofengeim, D., & Zukin, R. S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.140 · Cited by 113
Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types
James, M. F., Stivison, E., Beauchamp, R. L., Han, S., Li, H., Wallace, M. R., Gusella, J. F., Stemmer-Rachamimov, A. O., & Ramesh, V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0425-t · Cited by 112
Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1
Nardo, A. D., Wertz, M. H., Kwiatkowski, E. R., Tsai, P. T., Leech, J. D., Greene-Colozzi, E. A., Goto, J., Dilsiz, P., Talos, D. M., Clish, C. B., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu101 · Cited by 112
Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation
Melnik, B. C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817048 · Cited by 108
mTOR Inhibitors at a Glance.
Zheng, Y., & Jiang, Y. (2015) · PubMed · Cited by 109
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
Browne, I. M., André, F., Chandarlapaty, S., Carey, L., & Turner, N. C. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00676-9 · Cited by 116
Potential therapeutic effects of mTOR inhibition in atherosclerosis
Kurdi, A., Meyer, G. R. Y. D., & Martinet, W. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12820 · Cited by 111
AAV transduction of dopamine neurons with constitutively active rheb protects from neurodegeneration and mediates axon regrowth
Kim, S. R., Kareva, T., Yarygina, O., Kholodilov, N., & Burke, R. E. (2012) · Molecular Therapy · doi:10.1038/mt.2011.213 · Cited by 107
Lymphangioleiomyomatosis
Johnson, S. R., Taveira‐DaSilva, A. M., & Moss, J. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.04.002 · Cited by 109
Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy
Lundquist, M. R., Goncalves, M. D., Loughran, R. M., Possik, E., Vijayaraghavan, T., Yang, A., Pauli, C., Ravi, A., Verma, A., Yang, Z., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.037 · Cited by 112
Muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved?
Penna, F., Bonetto, A., Muscaritoli, M., Costamagna, D., Minero, V. G., Bonelli, G., Fanelli, F. R., Baccino, F. M., & Costelli, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.25146 · Cited by 109
Cellular and molecular effects of the mTOR inhibitor everolimus
Saran, U., Foti, M., & Dufour, J. (2015) · Clinical Science · doi:10.1042/cs20150149 · Cited by 111
Proteomic analysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response
Flowers, A., Bell‐Temin, H., Jalloh, A., Stevens, S. M., & Bickford, P. C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0840-7 · Cited by 107
The associations between Parkinson’s disease and cancer: the plot thickens
Feng, D. D., Cai, W., & Chen, X. M. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0043-z · Cited by 103
Negative regulation of mTOR activation by diacylglycerol kinases
Gorentla, B. K., Wan, E. C. K., & Zhong, X. (2011) · Blood · doi:10.1182/blood-2010-08-300731 · Cited by 108
A Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action
Chen, X.-W., Leto, D., Xiong, T., Yu, G., Cheng, A., Decker, S., & Saltiel, A. R. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0665 · Cited by 108
Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1α
Xu, D., Yao, Y., Lu, L., Costa, M., & Dai, W. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160325 · Cited by 100
Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex
Ercan-Herbst, E., Han, J. M., Nardo, A. D., Winden, K. D., Han, M., Hoyo, L., Saffari, A., Leask, A., Geschwind, D. H., & Şahin, M. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160446 · Cited by 100
Transcriptional regulation of the stress response by mTOR
Aramburu, J. F., Ortells, M. C., Vaquero, S. T., Buxadé, M., & López‐Rodríguez, C. (2014) · Science Signaling · doi:10.1126/scisignal.2005326 · Cited by 100
Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction
Noureldein, M. H., & Eid, A. A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.03.021 · Cited by 99
Signaling Determinants of Glioma Cell Invasion
Kwiatkowska, A., & Symons, M. H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_7 · Cited by 104
mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion
Quinn, W. J., Wan, M., Shewale, S. V., Gelfer, R., Rader, D. J., Birnbaum, M. J., & Titchenell, P. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96036 · Cited by 96
Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis
Taveira‐DaSilva, A. M., & Moss, J. (2015) · Clinical Epidemiology · doi:10.2147/clep.s50780 · Cited by 97
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Wang, Y., Yang, G., You, L., Yang, J., Feng, M., Qiu, J., Zhao, F., Liu, Y., Cao, Z., Zheng, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1103-2 · Cited by 97
The Akt signaling pathway
Madhunapantula, S. V., Mosca, P. J., & Robertson, G. P. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18442 · Cited by 96
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Sun, H., Yang, W., Tian, Y., Zeng, X., Zhou, J., Mok, M. T. S., Tang, W., Feng, Y., Xu, L., Chan, A. W. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07402-8 · Cited by 93
The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
Soliman, G. A. (2013) · Nutrients · doi:10.3390/nu5062231 · Cited by 97
Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle
Vandanmagsar, B., Warfel, J. D., Wicks, S. E., Ghosh, S., Salbaum, J. M., Burk, D., Dubuisson, O. S., Mendoza, T. M., Zhang, J., Noland, R. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.057 · Cited by 92
Tuberous sclerosis complex and Myc coordinate the growth and division ofDrosophilaintestinal stem cells
Amcheslavsky, A., Ito, N., Jiang, J., & Ip, Y. T. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201103018 · Cited by 90
Signaling Determinants of Glioma Cell Invasion
Kwiatkowska, A., & Symons, M. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_7 · Cited by 93
The Impact of Host Diet on Wolbachia Titer in Drosophila
Serbus, L. R., White, P. M., Silva, J. P., Rabe, A., Teixeira, L., Albertson, R., & Sullivan, W. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004777 · Cited by 90
Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation
Odusanwo, O., Chinthamani, S., McCall, A. D., Duffey, M. E., & Baker, O. J. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2011 · Cited by 90
Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases
Arrazola Sastre, A., Luque Montoro, M., Gálvez-Martín, P., Lacerda, H. M., Lucia, A., Llavero, F., & Zugaza, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176312 · Cited by 103
Akt/mTOR signalling in myelination
Norrmén, C., & Suter, U. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130046 · Cited by 89
Size control: the developmental physiology of body and organ size regulation
Gokhale, R. H., & Shingleton, A. W. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.181 · Cited by 93
Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscle
Moberg, M., Apró, W., & Blomstrand, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00353.2011 · Cited by 93
The incredible ULKs
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-7 · Cited by 92
The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC ‐γ 1 signalling in breast cancer cell migration and dissemination
Balz, L. M., Bartkowiak, K., Andreas, A., Pantel, K., Niggemann, B., Zänker, K. S., Brandt, B., & Dittmar, T. (2012) · The Journal of Pathology · doi:10.1002/path.3991 · Cited by 87
A Novel Signaling by Vitamin A/Retinol Promotes Self Renewal of Mouse Embryonic Stem Cells by Activating PI3K/Akt Signaling Pathway via Insulin-Like Growth Factor-1 Receptor
Chen, L., & Khillan, J. S. (2009) · Stem Cells · doi:10.1002/stem.251 · Cited by 87
mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells
Beirowski, B., Wong, K. M., Babetto, E., & Milbrandt, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620761114 · Cited by 88
The Promise of Slow Down Ageing May Come from Curcumin
Sikora, E., Bielak-Żmijewska, A., Mosieniak, G., & Piwocka, K. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790883507 · Cited by 84
A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells
Byun, J., Choi, Y., Kim, J. H., Jeong, J. Y., Jeon, H., Kim, M. K., Hwang, I., Lee, S.-Y., Lee, Y. M., Lee, I., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.066 · Cited by 87
The TORC2‐Dependent Signaling Network in the Yeast Saccharomyces cerevisiae
Roelants, F. M., Leskoske, K. L., Marshall, M. N. M., Locke, M. N., & Thorner, J. W. (2017) · Biomolecules · doi:10.3390/biom7030066 · Cited by 86
Tailoring mTOR-Based Therapy: Molecular Evidence and Clinical Challenges
Santulli, G., & Totary-Jain, H. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.143 · Cited by 84
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis
Head, S. A., Shi, W. Q., Yang, E. J., Nacev, B. A., Hong, S. Y., Pasunooti, K. K., Li, R.-J., Shim, J. S., & Liu, J. O. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b00849 · Cited by 82
Regulation of Akt during torpor in the hibernating ground squirrel, Ictidomys tridecemlineatus
McMullen, D. C., & Hallenbeck, J. M. (2010) · Journal of Comparative Physiology B · doi:10.1007/s00360-010-0468-8 · Cited by 80
Role of phospholipase C in cell invasion and metastasis
Lattanzio, R., Piantelli, M., & Falasca, M. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.07.006 · Cited by 81
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
Lu, C., Ning, Z., Wang, A., Chen, D., Liu, X., Xia, T., Tekcham, D. S., Wang, W., Li, T., Liu, X., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.032 · Cited by 81
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Turnham, D. J., Bullock, N., Dass, M. S., Staffurth, J. N., & Pearson, H. B. (2020) · Cells · doi:10.3390/cells9112342 · Cited by 85
PEComas of the kidney and of the genitourinary tract
Martignoni, G., Pea, M., Zampini, C., Brunelli, M., Segala, D., Zamboni, G., & Bonetti, F. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.006 · Cited by 81
Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas
Schultz, L., Chaux, A., Albadine, R., Hicks, J. L., Kim, J., Marzo, A. M. D., Allaf, M. E., Carducci, M. A., Rodríguez, R., Hammers, H.-J., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822895e5 · Cited by 79
Nutritional Programming in the Rat Is Linked to Long-Lasting Changes in Nutrient Sensing and Energy Homeostasis in the Hypothalamus
Orozco-Solís, R., de Matos, R. J. B., Guzmán‐Quevedo, O., de Souza, S. L., Bihouée, A., Houlgatte, R., Manhães‐de‐Castro, R., & Bolaños, F. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013537 · Cited by 83
Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors
Carson, R. P., Kelm, N. D., West, K. L., Does, M. D., Fu, C., Weaver, G., McBrier, E., Parker, B., Grier, M. D., & Ess, K. C. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.254 · Cited by 79
PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
Éthier, C., Tardif, M., Arul, L., & Poirier, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047978 · Cited by 82
Neurodegeneration in ataxia‐telangiectasia: Multiple roles of ATM kinase in cellular homeostasis
Choy, K. R., & Watters, D. J. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24522 · Cited by 80
Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/mTOR pathway in hepatoma cells
Pant, K., Saraya, A., & Venugopal, S. K. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.001 · Cited by 81
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
Ghosh, A. P., Marshall, C. B., Coric, T., Shim, E., Kirkman, R. L., Ballestas, M. E., Ikura, M., Bjornsti, M., & Sudarshan, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4963 · Cited by 78
Sensing invasion: Cell surface receptors driving spreading of glioblastoma
Teodorczyk, M., & Martín-Villalba, A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21901 · Cited by 77
Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes
Tan, S.-X., Ng, Y., Meoli, C. C., Kumar, A., Khoo, P., Fazakerley, D., Junutula, J., Vali, S., James, D. E., & Stöckli, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318238 · Cited by 75
Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
Herschbein, L., & Liesveld, J. L. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.11.006 · Cited by 76
Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy
Schultz, L., Albadine, R., Hicks, J. L., Jadallah, S., Marzo, A. M. D., Chen, Y., Neilsen, M. E., Gonzalgo, M. L., Sidransky, D., Schoenberg, M., et al. (2010) · Cancer · doi:10.1002/cncr.25502 · Cited by 75
Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin
Auernhammer, C. J., & Göke, B. (2011) · Gut · doi:10.1136/gut.2009.204453 · Cited by 75
Rheb Is Essential for Murine Development
Goorden, S. M. I., Hoogeveen‐Westerveld, M., Cheng, C., van Woerden, G. M., Mozaffari, M., Post, L. C., Duckers, H. J., Nellist, M. D., & Elgersma, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00985-10 · Cited by 75
Insulin-Like Peptide Signaling in Mosquitoes: The Road Behind and the Road Ahead
Sharma, A., Nuss, A. B., & Gulia-Nuss, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00166 · Cited by 74
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Platé, M., Guillotin, D., & Chambers, R. C. (2020) · European Respiratory Review · doi:10.1183/16000617.0269-2020 · Cited by 74
Reciprocal Regulation of AMP-activated Protein Kinase and Phospholipase D
Mukhopadhyay, S., Saqcena, M., Chatterjee, A., Garcia, A., Frías, M. A., & Foster, D. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.622571 · Cited by 72
Nuclear and mitochondrial signalling Akts in cardiomyocytes
Miyamoto, S., Rubio, M., & Sussman, M. A. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp087 · Cited by 72
Klotho Acts as a Tumor Suppressor in Cancers
Xie, B., Chen, J., Liu, B., & Zhan, J. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9663-8 · Cited by 77
An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris
Pretel, M., España, A., Marquina, M., Pelacho, B., López-Picazo, J. M., & López-Zabalza, M. J. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00893.x · Cited by 70
Transcriptomic analysis of crustacean molting gland (Y-organ) regulation via the mTOR signaling pathway
Shyamal, S., Das, S., Guruacharya, A., Mykles, D. L., & Durica, D. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25368-x · Cited by 73
Metabolic Role of PTEN in Insulin Signaling and ResistancePreprint
Li, Y. Z., Cristofano, A. D., & Woo, M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036137 · Cited by 76
From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68
The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
Gariboldi, M. B., Ravizza, R., & Monti, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.011 · Cited by 70
The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up‐regulation
Liu, D., Zhang, Y., Gharavi, R., Park, H. R., Lee, J., Siddiqui, S., Telljohann, R., Nassar, M. R., Cutler, R. G., Becker, K. G., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13176 · Cited by 68
Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy
Zheng, T., Jiang, T., Ma, H., Zhu, Y., & Wang, M. Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04039-1 · Cited by 71
Vitamin A/Retinol and Maintenance of Pluripotency of Stem Cells
Khillan, J. S. (2014) · Nutrients · doi:10.3390/nu6031209 · Cited by 68
14-3-3 Proteins are Regulators of Autophagy
Pozuelo-Rubio, M. (2012) · Cells · doi:10.3390/cells1040754 · Cited by 67
Skeletal Muscle Homeostasis in Duchenne Muscular Dystrophy: Modulating Autophagy as a Promising Therapeutic Strategy
Palma, C. D., Perrotta, C., Pellegrino, P., Clementi, E., & Cervia, D. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00188 · Cited by 66
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Kezić, A., Popović, L., & Lalic, K. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2640342 · Cited by 68
PTEN‐PI3K pathway alterations in advanced prostate cancer and clinical implications
Choudhury, A. D. (2022) · The Prostate · doi:10.1002/pros.24372 · Cited by 69
Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling
Syed, D. N., Chamcheu, J. C., Khan, M. I., Sechi, M., Lall, R. K., Adhami, V. M., & Mukhtar, H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.007 · Cited by 65
Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1 -Mutant Cancers
Malone, C. F., Longo, J. F., Maertens, O., Raedt, T. D., Ingraham, R., & Cichowski, K. M. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0159 · Cited by 65

Authors: Huang, J., & Manning, B. D.
Affiliations: Harvard University (US)
Corresponding author: Manning, Brendan D.
ORCID: Huang, Jingxiang
Manning, Brendan D.
Venue: Biochemical Society Transactions
Publisher: Portland Press Ltd.
Published: 2009-01-20
Volume: 37
Issue: 1
Pages: 217-222
ISSN: 0300-5127 (ISSN-L)
1470-8752
DOI: 10.1042/bst0370217
PMC: PMC2778026
OpenAlex: W2065322400
Cited by: 724
References: 35
Citations by year: 2026: 17 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 31 · 2020: 37 · 2019: 40 · 2018: 49 · 2017: 40 · 2016: 38 · 2015: 53 · 2014: 60 · 2013: 51 · 2012: 67
FWCI: 5.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Biochemical Society Transactions (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA122617, P01CA120964)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Akt, TSC1/TSC2 complex, tuberous sclerosis complex, mTORC1, mTORC2, PI3K signaling, Rheb, Akt phosphorylation, negative feedback regulation, growth factor signaling, tumor growth
MeSH terms: Tuberous Sclerosis Complex 2 Protein, Animals, Humans, Protein Kinases, Transcription Factors, Phosphatidylinositol 3-Kinases, Feedback, Physiological, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A complex interplay between Akt, TSC2 and the two mTOR complexes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks